Table 2.
Antibiotic susceptibility pattern of GBS isolates in Iran, (January – April, 2008).
| Antibiotics | Susceptibility profile | ||
|---|---|---|---|
|
|
|||
| Sensitive n (%) | Intermediate n(%) | Resistant n(%) | |
| Penicillina | 56 (100) | - | - |
| Ampicillina | 56 (100) | - | - |
| Erythromycina | 53 (94.7) | 3 (5.3) | - |
| Clindamycina | 52 (93) | 2 (3.5) | 2 (3.5) |
| Vancomycina | 56(100) | - | - |
| Cefazolinb | 55 (98.2) | 1 (1.78)- | - |
| Ceftriaxoneb | 4 (7.1) | 45 (80.3) | 7(12.5%) |
| Ciprofloxacinb | 4 (7.1) | 44 (78.5) | 8 (14.2) |
| Co-trimoxazoleb | 8 (14.2) | 1 (1.78) | 47 (83.9) |
a
Susceptibility pattern was determined by E-test strips
b
Susceptibility pattern was determined by disk diffusion method